
Jiping 'Jay' Zeng, MD
@urozeng
@UroOnc fellow @IUUro. Stops along the way @UAUrology @UNMC. Views are my own. RT≠E
ID: 882384573040119808
04-07-2017 23:44:10
229 Tweet
327 Followers
337 Following

I saw there was some voicemail trend thing going on on TikTok so I wanted to share this one from almost 5 years ago I got from Clint Cary, MD MPH MBA! Testicular Cancer #testicularcancerawareness #testicularcancer #testicularcancersurvivor


We are so excited to introduce our newest incoming Society of Urologic Oncology fellow Dr. Adri Durant (Adri Durant) from Mayo Clinic Urology Arizona. Thrilled to have you train with us and continue to advance the field of urologic oncology!



Don’t miss the latest issue of @Urologic Clinics, edited by Jeffrey Holzbeierlein & Dr. Phillipe Speiss on Advances in #Penile and #Testicular #Cancer! Thank you to our authors & editors for detailing the contemporary clinical concepts & #treatment standards. urologic.theclinics.com/current.


Dr. Jiping Zeng (Jiping 'Jay' Zeng, MD), Dr. Timothy Masterson, and Dr. Clint Cary (Clint Cary, MD MPH MBA) discuss the evolving role of surgery in seminoma. Indiana University Department of Urology #urology urologytimes.com/view/the-role-…

Incredible evening celebrating the 50th anniversary of the cure of testicular cancer at Indiana University with Dr. Einhorn, Lance Armstrong, and other colleagues/survivors/etc!!!





Thoughtful discussion by Clint Cary, MD MPH MBA of Indiana University Department of Urology regarding surgery in early metastatic seminoma. IU Simon Comprehensive Cancer Center Testicular Cancer


Very proud of our 1st and 2nd year urologic oncology fellows Jiping 'Jay' Zeng, MD and Parth Thakker @ GU ASCO ‘25 presenting our work Indiana University Department of Urology IU Simon Comprehensive Cancer Center on ctDNA in GCTs and stage II Embryonal predominant GCT outcomes RPLND vs. chemotherapy

Our fellows regularly present abstracts at ASCO and at Amer. Urol. Assn.. This year, both Jiping 'Jay' Zeng, MD and Parth Thakker, MD presented on the outcomes of stage 2 EC predominant undergoing RPLND vs chemotherapy & the role of ctDNA in GCT under Timothy Masterson and Clint Cary, MD MPH MBA.


Fortunate to work with an incredible team! IU group at GU ASCO Clint Cary, MD MPH MBA Jennifer King Tareq Salous Stephanie Schneck IU Simon Comprehensive Cancer Center Indiana University Department of Urology IU_UroOnc Rebecca Hassoun Ahmed Bilal Khalid Noah Richardson #GU25


Treating metastatic seminoma? Considering offering primary RPLND for early CS2 disease? Learn about the dissemination pattern of the disease and if a modified template is appropriate for these patients. Journal of Urology Jiping 'Jay' Zeng, MD Clint Cary, MD MPH MBA


Congratulations to our PGY 2 Connor Drake and Society of Urologic Oncology fellows, Parth Thakker, MD & Jiping 'Jay' Zeng, MD with the mentorship of Tim Masterson and Clint Cary, MD MPH MBA. Best poster award was given for their work regarding the utility of ctDNA in testicular germ cell tumor. IU Simon Comprehensive Cancer Center Indiana University Department of Urology



Beautiful night celebrating our graduating chief residents Indiana University Department of Urology and our 5 graduating fellows of oncology, peds, endourology, men's health, and female urology. Packed event including prior Alumni!! Best of Luck!!!
